Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Inflammatory Bowel Diseases|May 23, 2024
Prebiotics for Induction and Maintenance of Remission in Inflammatory Bowel Disease: Systematic Review and Meta-AnalysisBerkeley N Limketkai, Gala Godoy-Brewer, Neha D Shah, et al.
The American Journal of Gastroenterology|May 18, 2021
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile InfectionsColleen R Kelly, Monika Fischer, Jessica R Allegretti, et al.
The American Journal of Gastroenterology|July 23, 2025
ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel DiseaseFrancis A Farraye, Gil Y Melmed, Gary R Lichtenstein, et al.
The American Journal of Gastroenterology|January 5, 2023
American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac DiseaseAlberto Rubio-Tapia, Ivor D Hill, Carol Semrad, et al.
JAMA Network Open|July 21, 2023
Trends in the Prevalence of Hepatitis C Infection During Pregnancy and Maternal-Infant Outcomes in the US, 1998 to 2018Po-Hung Chen, Lauren Johnson, Berkeley N Limketkai, et al.
The American Journal of Gastroenterology|June 28, 2023
Acute Liver Failure GuidelinesAlexandra Shingina, Nizar Mukhtar, Jamilé Wakim-Fleming, et al.
The American Journal of Surgical Pathology|August 15, 2014
Gastrointestinal tract-derived pulse granulomata: clues to an underrecognized pseudotumorNicholas B Nowacki, Michael A Arnold, Wendy L Frankel, et al.
United European Gastroenterology Journal|June 18, 2025
Dietary Sugar and Sweetened Beverage Intake Increases Inflammatory Bowel Disease Risk: A Systematic Review and Meta-AnalysisIsha Maniyar, Arpita Jajoo, Gala Godoy Brewer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 5, 2022
Dietary Interventions for the Treatment of Inflammatory Bowel Diseases: An Updated Systematic Review and Meta-analysisBerkeley N Limketkai, Gala Godoy-Brewer, Alyssa M Parian, et al.
Gut|November 14, 2018
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohortsRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
Pageof 12